PNC Financial Services Group’s Tonix Pharmaceuticals TNXP Stock Holding History

PNC Financial Services Group’s Portfolio TNXP Stock Details TNXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.14K	Buy	+168	New	+$2.17K	﹤0.01%	4656
2023 Q3	–	Hold	0	–	-$254	–	4756
2023 Q2	–	Hold	0	–	–	–	4650
2023 Q1	–	Hold	0	–	–	–	4507
2022 Q4	–	Hold	0	–	–	–	4563
2022 Q3	–	Hold	0	–	–	–	4351
2022 Q2	–	Hold	0	–	–	–	4242

Other funds holding TNXP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JHC

Jones Hill Capital New York $470M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ishara Investments Los Angeles, California $136M AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

PNC Financial Services Group's TNXP Position: Q2 2026 in Review

PNC Financial Services Group opened a new position in Tonix Pharmaceuticals (TNXP) in Q2 2026: 168 shares worth $2.14K. The stake represents ﹤0.01% of the portfolio and ranks #4656 among its holdings.

103 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

PNC Financial Services Group held 168 shares of Tonix Pharmaceuticals worth $2.14K as of Q2 2026.
Tonix Pharmaceuticals was a new PNC Financial Services Group position in Q2 2026.
Tonix Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4656 holding.
103 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.